APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Drug

Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.

Selected research

Market Analysis & Forecast

Global Veterinary Drug Market Analysis and Forecast 2026-2032

28 December 2025209 pages

Choose your research edition.

Industry ResearchVeterinary Drug Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Drug Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Veterinary Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Drug Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Drug Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.

The key players of Veterinary Drug include Zoetis, Elanco, Boehringer Ingelheim, Merck, etc. The top four players of Veterinary Drug account for approximately 56% of the total market. Asia-Pacific is the largest market of Veterinary Drug accounting for about 34%, followed by Europe and North America. In terms of Type, Parasiticides is the largest segment, with a share about 28%. And in terms of Application, the largest application is Pets, followed by Cattle.

This report presents an overview of global market for Veterinary Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Veterinary Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Veterinary Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Veterinary Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Veterinary Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Veterinary Drug sales, projected growth trends, production technology, application and end-user industry.

Veterinary Drug Segment by Company

Zoetis

Elanco

Boehringer Ingelheim

Merck

Virbac

Ceva

Vetoquinol

Dechra

Norbrook

Phibro

Huvepharma

Hipra

Ouro Fino Saude

CAHIC

Orion

Ringpu Biology

Nippon Zenyaku Kogyo

Farmavet-Pasteur

Veterinary Drug Segment by Type

Anti-Infectives

Anti-Inflammatory

Parasiticides

Analgesics

Sedatives

Others

Veterinary Drug Segment by Application

Pets

Cattle

Poultry

Swine

Others

Veterinary Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Veterinary Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Veterinary Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Veterinary Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Anti-Infectives Major Manufacturers Table 3. Anti-Inflammatory Major Manufacturers Table 4. Parasiticides Major Manufacturers Table 5. Analgesics Major Manufacturers Table 6. Sedatives Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Veterinary Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Pets Major Manufacturers Table 10. Cattle Major Manufacturers Table 11. Poultry Major Manufacturers Table 12. Swine Major Manufacturers Table 13. Others Major Manufacturers Table 14. Veterinary Drug Industry Trends Table 15. Veterinary Drug Industry Drivers Table 16. Veterinary Drug Industry Opportunities and Challenges Table 17. Veterinary Drug Industry Restraints Table 18. Global Veterinary Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Veterinary Drug Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Veterinary Drug Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Veterinary Drug Revenue Market Share by Region (2021-2026) Table 22. Global Veterinary Drug Revenue Market Share by Region (2027-2032) Table 23. Global Veterinary Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Units) Table 24. Global Veterinary Drug Sales by Region (2021-2026) & (M Units) Table 25. Global Veterinary Drug Sales by Region (2027-2032) & (M Units) Table 26. Global Veterinary Drug Sales Market Share by Region (2021-2026) Table 27. Global Veterinary Drug Sales Market Share by Region (2027-2032) Table 28. Global Veterinary Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Veterinary Drug Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Veterinary Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Veterinary Drug Sales Market Share by Manufacturers (2021-2026) Table 32. Global Veterinary Drug Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 33. Global Veterinary Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Veterinary Drug Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Veterinary Drug Manufacturers, Product Type & Application Table 36. Global Veterinary Drug Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Veterinary Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Veterinary Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Veterinary Drug Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Veterinary Drug Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Veterinary Drug Revenue Market Share by Type (2021-2026) Table 43. Global Veterinary Drug Revenue Market Share by Type (2027-2032) Table 44. Global Veterinary Drug Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 45. Global Veterinary Drug Sales by Type (2021-2026) & (M Units) Table 46. Global Veterinary Drug Sales by Type (2027-2032) & (M Units) Table 47. Global Veterinary Drug Sales Market Share by Type (2021-2026) Table 48. Global Veterinary Drug Sales Market Share by Type (2027-2032) Table 49. Global Veterinary Drug Price by Type (2021-2026) & (USD/Unit) Table 50. Global Veterinary Drug Price by Type (2027-2032) & (USD/Unit) Table 51. Global Veterinary Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Veterinary Drug Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Veterinary Drug Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Veterinary Drug Revenue Market Share by Application (2021-2026) Table 55. Global Veterinary Drug Revenue Market Share by Application (2027-2032) Table 56. Global Veterinary Drug Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 57. Global Veterinary Drug Sales by Application (2021-2026) & (M Units) Table 58. Global Veterinary Drug Sales by Application (2027-2032) & (M Units) Table 59. Global Veterinary Drug Sales Market Share by Application (2021-2026) Table 60. Global Veterinary Drug Sales Market Share by Application (2027-2032) Table 61. Global Veterinary Drug Price by Application (2021-2026) & (USD/Unit) Table 62. Global Veterinary Drug Price by Application (2027-2032) & (USD/Unit) Table 63. Zoetis Company Information Table 64. Zoetis Business Overview Table 65. Zoetis Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Zoetis Veterinary Drug Product Portfolio Table 67. Zoetis Recent Development Table 68. Elanco Company Information Table 69. Elanco Business Overview Table 70. Elanco Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Elanco Veterinary Drug Product Portfolio Table 72. Elanco Recent Development Table 73. Boehringer Ingelheim Company Information Table 74. Boehringer Ingelheim Business Overview Table 75. Boehringer Ingelheim Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Boehringer Ingelheim Veterinary Drug Product Portfolio Table 77. Boehringer Ingelheim Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Merck Veterinary Drug Product Portfolio Table 82. Merck Recent Development Table 83. Virbac Company Information Table 84. Virbac Business Overview Table 85. Virbac Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Virbac Veterinary Drug Product Portfolio Table 87. Virbac Recent Development Table 88. Ceva Company Information Table 89. Ceva Business Overview Table 90. Ceva Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Ceva Veterinary Drug Product Portfolio Table 92. Ceva Recent Development Table 93. Vetoquinol Company Information Table 94. Vetoquinol Business Overview Table 95. Vetoquinol Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Vetoquinol Veterinary Drug Product Portfolio Table 97. Vetoquinol Recent Development Table 98. Dechra Company Information Table 99. Dechra Business Overview Table 100. Dechra Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Dechra Veterinary Drug Product Portfolio Table 102. Dechra Recent Development Table 103. Norbrook Company Information Table 104. Norbrook Business Overview Table 105. Norbrook Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Norbrook Veterinary Drug Product Portfolio Table 107. Norbrook Recent Development Table 108. Phibro Company Information Table 109. Phibro Business Overview Table 110. Phibro Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. Phibro Veterinary Drug Product Portfolio Table 112. Phibro Recent Development Table 113. Huvepharma Company Information Table 114. Huvepharma Business Overview Table 115. Huvepharma Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. Huvepharma Veterinary Drug Product Portfolio Table 117. Huvepharma Recent Development Table 118. Hipra Company Information Table 119. Hipra Business Overview Table 120. Hipra Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 121. Hipra Veterinary Drug Product Portfolio Table 122. Hipra Recent Development Table 123. Ouro Fino Saude Company Information Table 124. Ouro Fino Saude Business Overview Table 125. Ouro Fino Saude Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 126. Ouro Fino Saude Veterinary Drug Product Portfolio Table 127. Ouro Fino Saude Recent Development Table 128. CAHIC Company Information Table 129. CAHIC Business Overview Table 130. CAHIC Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 131. CAHIC Veterinary Drug Product Portfolio Table 132. CAHIC Recent Development Table 133. Orion Company Information Table 134. Orion Business Overview Table 135. Orion Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 136. Orion Veterinary Drug Product Portfolio Table 137. Orion Recent Development Table 138. Ringpu Biology Company Information Table 139. Ringpu Biology Business Overview Table 140. Ringpu Biology Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 141. Ringpu Biology Veterinary Drug Product Portfolio Table 142. Ringpu Biology Recent Development Table 143. Nippon Zenyaku Kogyo Company Information Table 144. Nippon Zenyaku Kogyo Business Overview Table 145. Nippon Zenyaku Kogyo Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 146. Nippon Zenyaku Kogyo Veterinary Drug Product Portfolio Table 147. Nippon Zenyaku Kogyo Recent Development Table 148. Farmavet-Pasteur Company Information Table 149. Farmavet-Pasteur Business Overview Table 150. Farmavet-Pasteur Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 151. Farmavet-Pasteur Veterinary Drug Product Portfolio Table 152. Farmavet-Pasteur Recent Development Table 153. North America Veterinary Drug Revenue by Type (2021-2026) & (US$ Million) Table 154. North America Veterinary Drug Revenue by Type (2027-2032) & (US$ Million) Table 155. North America Veterinary Drug Sales by Type (2021-2026) & (M Units) Table 156. North America Veterinary Drug Sales by Type (2027-2032) & (M Units) Table 157. North America Veterinary Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 158. North America Veterinary Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 159. North America Veterinary Drug Revenue by Application (2021-2026) & (US$ Million) Table 160. North America Veterinary Drug Revenue by Application (2027-2032) & (US$ Million) Table 161. North America Veterinary Drug Sales by Application (2021-2026) & (M Units) Table 162. North America Veterinary Drug Sales by Application (2027-2032) & (M Units) Table 163. North America Veterinary Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 164. North America Veterinary Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 165. North America Veterinary Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. North America Veterinary Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. North America Veterinary Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. North America Veterinary Drug Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 169. North America Veterinary Drug Sales by Country (2021-2026) & (M Units) Table 170. North America Veterinary Drug Sales by Country (2027-2032) & (M Units) Table 171. North America Veterinary Drug Sales Price by Country (2021-2026) & (USD/Unit) Table 172. North America Veterinary Drug Sales Price by Country (2027-2032) & (USD/Unit) Table 173. United States Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 174. Canada Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 175. Mexico Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 176. Europe Veterinary Drug Revenue by Type (2021-2026) & (US$ Million) Table 177. Europe Veterinary Drug Revenue by Type (2027-2032) & (US$ Million) Table 178. Europe Veterinary Drug Sales by Type (2021-2026) & (M Units) Table 179. Europe Veterinary Drug Sales by Type (2027-2032) & (M Units) Table 180. Europe Veterinary Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 181. Europe Veterinary Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 182. Europe Veterinary Drug Revenue by Application (2021-2026) & (US$ Million) Table 183. Europe Veterinary Drug Revenue by Application (2027-2032) & (US$ Million) Table 184. Europe Veterinary Drug Sales by Application (2021-2026) & (M Units) Table 185. Europe Veterinary Drug Sales by Application (2027-2032) & (M Units) Table 186. Europe Veterinary Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 187. Europe Veterinary Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 188. Europe Veterinary Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 189. Europe Veterinary Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 190. Europe Veterinary Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 191. Europe Veterinary Drug Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 192. Europe Veterinary Drug Sales by Country (2021-2026) & (M Units) Table 193. Europe Veterinary Drug Sales by Country (2027-2032) & (M Units) Table 194. Europe Veterinary Drug Sales Price by Country (2021-2026) & (USD/Unit) Table 195. Europe Veterinary Drug Sales Price by Country (2027-2032) & (USD/Unit) Table 196. Germany Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 197. France Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 198. U.K. Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 199. Italy Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 200. Russia Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 201. Spain Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 202. Netherlands Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 203. Switzerland Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 204. Sweden Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 205. Poland Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 206. China Veterinary Drug Revenue by Type (2021-2026) & (US$ Million) Table 207. China Veterinary Drug Revenue by Type (2027-2032) & (US$ Million) Table 208. China Veterinary Drug Sales by Type (2021-2026) & (M Units) Table 209. China Veterinary Drug Sales by Type (2027-2032) & (M Units) Table 210. China Veterinary Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 211. China Veterinary Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 212. China Veterinary Drug Revenue by Application (2021-2026) & (US$ Million) Table 213. China Veterinary Drug Revenue by Application (2027-2032) & (US$ Million) Table 214. China Veterinary Drug Sales by Application (2021-2026) & (M Units) Table 215. China Veterinary Drug Sales by Application (2027-2032) & (M Units) Table 216. China Veterinary Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 217. China Veterinary Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 218. Asia Veterinary Drug Revenue by Type (2021-2026) & (US$ Million) Table 219. Asia Veterinary Drug Revenue by Type (2027-2032) & (US$ Million) Table 220. Asia Veterinary Drug Sales by Type (2021-2026) & (M Units) Table 221. Asia Veterinary Drug Sales by Type (2027-2032) & (M Units) Table 222. Asia Veterinary Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 223. Asia Veterinary Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 224. Asia Veterinary Drug Revenue by Application (2021-2026) & (US$ Million) Table 225. Asia Veterinary Drug Revenue by Application (2027-2032) & (US$ Million) Table 226. Asia Veterinary Drug Sales by Application (2021-2026) & (M Units) Table 227. Asia Veterinary Drug Sales by Application (2027-2032) & (M Units) Table 228. Asia Veterinary Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 229. Asia Veterinary Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 230. Asia Veterinary Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 231. Asia Veterinary Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 232. Asia Veterinary Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 233. Asia Veterinary Drug Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 234. Asia Veterinary Drug Sales by Country (2021-2026) & (M Units) Table 235. Asia Veterinary Drug Sales by Country (2027-2032) & (M Units) Table 236. Asia Veterinary Drug Sales Price by Country (2021-2026) & (USD/Unit) Table 237. Asia Veterinary Drug Sales Price by Country (2027-2032) & (USD/Unit) Table 238. Japan Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 239. South Korea Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 240. India Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 241. Australia Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 242. Taiwan Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 243. Southeast Asia Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 244. SAMEA Veterinary Drug Revenue by Type (2021-2026) & (US$ Million) Table 245. SAMEA Veterinary Drug Revenue by Type (2027-2032) & (US$ Million) Table 246. SAMEA Veterinary Drug Sales by Type (2021-2026) & (M Units) Table 247. SAMEA Veterinary Drug Sales by Type (2027-2032) & (M Units) Table 248. SAMEA Veterinary Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 249. SAMEA Veterinary Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 250. SAMEA Veterinary Drug Revenue by Application (2021-2026) & (US$ Million) Table 251. SAMEA Veterinary Drug Revenue by Application (2027-2032) & (US$ Million) Table 252. SAMEA Veterinary Drug Sales by Application (2021-2026) & (M Units) Table 253. SAMEA Veterinary Drug Sales by Application (2027-2032) & (M Units) Table 254. SAMEA Veterinary Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 255. SAMEA Veterinary Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 256. SAMEA Veterinary Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 257. SAMEA Veterinary Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 258. SAMEA Veterinary Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 259. SAMEA Veterinary Drug Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 260. SAMEA Veterinary Drug Sales by Country (2021-2026) & (M Units) Table 261. SAMEA Veterinary Drug Sales by Country (2027-2032) & (M Units) Table 262. SAMEA Veterinary Drug Sales Price by Country (2021-2026) & (USD/Unit) Table 263. SAMEA Veterinary Drug Sales Price by Country (2027-2032) & (USD/Unit) Table 264. Brazil Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 265. Argentina Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 266. Chile Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 267. Colombia Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 268. Peru Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 269. Saudi Arabia Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 270. Israel Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 271. UAE Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 272. Turkey Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 273. Iran Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 274. Egypt Veterinary Drug Revenue (2021-2032) & (US$ Million) Table 275. Key Raw Materials Table 276. Raw Materials Key Suppliers Table 277. Veterinary Drug Distributors List Table 278. Veterinary Drug Customers List Table 279. Research Programs/Design for This Report Table 280. Authors List of This Report Table 281. Secondary Sources Table 282. Primary Sources List of Figures Figure 1. Veterinary Drug Image Figure 2. Global Veterinary Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Anti-Infectives Image Figure 5. Anti-Inflammatory Image Figure 6. Parasiticides Image Figure 7. Analgesics Image Figure 8. Sedatives Image Figure 9. Others Image Figure 10. Global Veterinary Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Veterinary Drug Market Size Share 2021 VS 2025 VS 2032 Figure 12. Pets Image Figure 13. Cattle Image Figure 14. Poultry Image Figure 15. Swine Image Figure 16. Others Image Figure 17. Global Veterinary Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Veterinary Drug Revenue (2021-2032) & (US$ Million) Figure 19. Global Veterinary Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Veterinary Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Veterinary Drug Revenue Market Share by Region (2021-2032) Figure 22. Global Veterinary Drug Sales (2021-2032) & (M Units) Figure 23. Global Veterinary Drug Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 24. Global Veterinary Drug Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico Veterinary Drug Sales YoY (2021-2032) & (M Units) Figure 26. Europe Veterinary Drug Sales YoY (2021-2032) & (M Units) Figure 27. China Veterinary Drug Sales YoY (2021-2032) & (M Units) Figure 28. Asia (Excluding China) Veterinary Drug Sales YoY (2021-2032) & (M Units) Figure 29. South America, Middle East and Africa Veterinary Drug Sales YoY (2021-2032) & (M Units) Figure 30. Global Veterinary Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Veterinary Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Veterinary Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Veterinary Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Veterinary Drug Revenue Market Share by Type (2021-2032) Figure 36. Global Veterinary Drug Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 37. Global Veterinary Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Veterinary Drug Sales Market Share by Type (2021-2032) Figure 39. Global Veterinary Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global Veterinary Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Veterinary Drug Revenue Market Share by Application (2021-2032) Figure 42. Global Veterinary Drug Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 43. Global Veterinary Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Veterinary Drug Sales Market Share by Application (2021-2032) Figure 45. North America Veterinary Drug Revenue Share by Type (2021-2032) Figure 46. North America Veterinary Drug Sales Share by Type (2021-2032) Figure 47. North America Veterinary Drug Revenue Share by Application (2021-2032) Figure 48. North America Veterinary Drug Sales Share by Application (2021-2032) Figure 49. North America Veterinary Drug Revenue Share by Country (2021-2032) Figure 50. North America Veterinary Drug Sales Share by Country (2021-2032) Figure 51. Europe Veterinary Drug Revenue Share by Type (2021-2032) Figure 52. Europe Veterinary Drug Sales Share by Type (2021-2032) Figure 53. Europe Veterinary Drug Revenue Share by Application (2021-2032) Figure 54. Europe Veterinary Drug Sales Share by Application (2021-2032) Figure 55. Europe Veterinary Drug Revenue Share by Country (2021-2032) Figure 56. Europe Veterinary Drug Sales Share by Country (2021-2032) Figure 57. China Veterinary Drug Revenue Share by Type (2021-2032) Figure 58. China Veterinary Drug Sales Share by Type (2021-2032) Figure 59. China Veterinary Drug Revenue Share by Application (2021-2032) Figure 60. China Veterinary Drug Sales Share by Application (2021-2032) Figure 61. Asia Veterinary Drug Revenue Share by Type (2021-2032) Figure 62. Asia Veterinary Drug Sales Share by Type (2021-2032) Figure 63. Asia Veterinary Drug Revenue Share by Application (2021-2032) Figure 64. Asia Veterinary Drug Sales Share by Application (2021-2032) Figure 65. Asia Veterinary Drug Revenue Share by Country (2021-2032) Figure 66. Asia Veterinary Drug Sales Share by Country (2021-2032) Figure 67. SAMEA Veterinary Drug Revenue Share by Type (2021-2032) Figure 68. SAMEA Veterinary Drug Sales Share by Type (2021-2032) Figure 69. SAMEA Veterinary Drug Revenue Share by Application (2021-2032) Figure 70. SAMEA Veterinary Drug Sales Share by Application (2021-2032) Figure 71. SAMEA Veterinary Drug Revenue Share by Country (2021-2032) Figure 72. SAMEA Veterinary Drug Sales Share by Country (2021-2032) Figure 73. Veterinary Drug Value Chain Figure 74. Manufacturing Cost Structure Figure 75. Veterinary Drug Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-Infectives
  • Anti-Inflammatory
  • Parasiticides
  • Analgesics
  • Sedatives
  • Others
Applications
  • Pets
  • Cattle
  • Poultry
  • Swine
  • Others
Companies covered
  • Zoetis
  • Elanco
  • Boehringer Ingelheim
  • Merck
  • Virbac
  • Ceva
  • Vetoquinol
  • Dechra
  • Norbrook
  • Phibro
  • Huvepharma
  • Hipra
  • Ouro Fino Saude
  • CAHIC
  • Orion
  • Ringpu Biology
  • Nippon Zenyaku Kogyo
  • Farmavet-Pasteur

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Veterinary Drug Market by Type
  3. 1.2.1 Global Veterinary Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Anti-Infectives
  5. 1.2.3 Anti-Inflammatory
  6. 1.2.4 Parasiticides
  7. 1.2.5 Analgesics
  8. 1.2.6 Sedatives
  9. 1.2.7 Others
  10. 1.3 Veterinary Drug Market by Application
  11. 1.3.1 Global Veterinary Drug Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Pets
  13. 1.3.3 Cattle
  14. 1.3.4 Poultry
  15. 1.3.5 Swine
  16. 1.3.6 Others
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Veterinary Drug Market Dynamics
  1. 2.1 Veterinary Drug Industry Trends
  2. 2.2 Veterinary Drug Industry Drivers
  3. 2.3 Veterinary Drug Industry Opportunities and Challenges
  4. 2.4 Veterinary Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Veterinary Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Veterinary Drug Revenue by Region
  3. 3.2.1 Global Veterinary Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Veterinary Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Veterinary Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Veterinary Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Veterinary Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Veterinary Drug Sales by Region
  9. 3.4.1 Global Veterinary Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Veterinary Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Veterinary Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Veterinary Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Veterinary Drug Revenue by Manufacturers
  2. 4.1.1 Global Veterinary Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Veterinary Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Veterinary Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Veterinary Drug Sales by Manufacturers
  6. 4.2.1 Global Veterinary Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Veterinary Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Veterinary Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Veterinary Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Veterinary Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Veterinary Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Veterinary Drug Manufacturers, Product Type & Application
  13. 4.7 Global Veterinary Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Veterinary Drug Market CR5 and HHI
  16. 4.8.2 2025 Veterinary Drug Tier 1, Tier 2, and Tier 3
5 Veterinary Drug Market by Type
  1. 5.1 Global Veterinary Drug Revenue by Type
  2. 5.1.1 Global Veterinary Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Veterinary Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Veterinary Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Veterinary Drug Sales by Type
  6. 5.2.1 Global Veterinary Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Veterinary Drug Sales by Type (2021-2032) & (M Units)
  8. 5.2.3 Global Veterinary Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Veterinary Drug Price by Type
6 Veterinary Drug Market by Application
  1. 6.1 Global Veterinary Drug Revenue by Application
  2. 6.1.1 Global Veterinary Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Veterinary Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Veterinary Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Veterinary Drug Sales by Application
  6. 6.2.1 Global Veterinary Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Veterinary Drug Sales by Application (2021-2032) & (M Units)
  8. 6.2.3 Global Veterinary Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Veterinary Drug Price by Application
7 Company Profiles
  1. 7.1 Zoetis
  2. 7.1.1 Zoetis Company Information
  3. 7.1.2 Zoetis Business Overview
  4. 7.1.3 Zoetis Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zoetis Veterinary Drug Product Portfolio
  6. 7.1.5 Zoetis Recent Developments
  7. 7.2 Elanco
  8. 7.2.1 Elanco Company Information
  9. 7.2.2 Elanco Business Overview
  10. 7.2.3 Elanco Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Elanco Veterinary Drug Product Portfolio
  12. 7.2.5 Elanco Recent Developments
  13. 7.3 Boehringer Ingelheim
  14. 7.3.1 Boehringer Ingelheim Company Information
  15. 7.3.2 Boehringer Ingelheim Business Overview
  16. 7.3.3 Boehringer Ingelheim Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Boehringer Ingelheim Veterinary Drug Product Portfolio
  18. 7.3.5 Boehringer Ingelheim Recent Developments
  19. 7.4 Merck
  20. 7.4.1 Merck Company Information
  21. 7.4.2 Merck Business Overview
  22. 7.4.3 Merck Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Merck Veterinary Drug Product Portfolio
  24. 7.4.5 Merck Recent Developments
  25. 7.5 Virbac
  26. 7.5.1 Virbac Company Information
  27. 7.5.2 Virbac Business Overview
  28. 7.5.3 Virbac Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Virbac Veterinary Drug Product Portfolio
  30. 7.5.5 Virbac Recent Developments
  31. 7.6 Ceva
  32. 7.6.1 Ceva Company Information
  33. 7.6.2 Ceva Business Overview
  34. 7.6.3 Ceva Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Ceva Veterinary Drug Product Portfolio
  36. 7.6.5 Ceva Recent Developments
  37. 7.7 Vetoquinol
  38. 7.7.1 Vetoquinol Company Information
  39. 7.7.2 Vetoquinol Business Overview
  40. 7.7.3 Vetoquinol Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Vetoquinol Veterinary Drug Product Portfolio
  42. 7.7.5 Vetoquinol Recent Developments
  43. 7.8 Dechra
  44. 7.8.1 Dechra Company Information
  45. 7.8.2 Dechra Business Overview
  46. 7.8.3 Dechra Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Dechra Veterinary Drug Product Portfolio
  48. 7.8.5 Dechra Recent Developments
  49. 7.9 Norbrook
  50. 7.9.1 Norbrook Company Information
  51. 7.9.2 Norbrook Business Overview
  52. 7.9.3 Norbrook Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Norbrook Veterinary Drug Product Portfolio
  54. 7.9.5 Norbrook Recent Developments
  55. 7.10 Phibro
  56. 7.10.1 Phibro Company Information
  57. 7.10.2 Phibro Business Overview
  58. 7.10.3 Phibro Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Phibro Veterinary Drug Product Portfolio
  60. 7.10.5 Phibro Recent Developments
  61. 7.11 Huvepharma
  62. 7.11.1 Huvepharma Company Information
  63. 7.11.2 Huvepharma Business Overview
  64. 7.11.3 Huvepharma Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Huvepharma Veterinary Drug Product Portfolio
  66. 7.11.5 Huvepharma Recent Developments
  67. 7.12 Hipra
  68. 7.12.1 Hipra Company Information
  69. 7.12.2 Hipra Business Overview
  70. 7.12.3 Hipra Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Hipra Veterinary Drug Product Portfolio
  72. 7.12.5 Hipra Recent Developments
  73. 7.13 Ouro Fino Saude
  74. 7.13.1 Ouro Fino Saude Company Information
  75. 7.13.2 Ouro Fino Saude Business Overview
  76. 7.13.3 Ouro Fino Saude Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Ouro Fino Saude Veterinary Drug Product Portfolio
  78. 7.13.5 Ouro Fino Saude Recent Developments
  79. 7.14 CAHIC
  80. 7.14.1 CAHIC Company Information
  81. 7.14.2 CAHIC Business Overview
  82. 7.14.3 CAHIC Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 CAHIC Veterinary Drug Product Portfolio
  84. 7.14.5 CAHIC Recent Developments
  85. 7.15 Orion
  86. 7.15.1 Orion Company Information
  87. 7.15.2 Orion Business Overview
  88. 7.15.3 Orion Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Orion Veterinary Drug Product Portfolio
  90. 7.15.5 Orion Recent Developments
  91. 7.16 Ringpu Biology
  92. 7.16.1 Ringpu Biology Company Information
  93. 7.16.2 Ringpu Biology Business Overview
  94. 7.16.3 Ringpu Biology Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Ringpu Biology Veterinary Drug Product Portfolio
  96. 7.16.5 Ringpu Biology Recent Developments
  97. 7.17 Nippon Zenyaku Kogyo
  98. 7.17.1 Nippon Zenyaku Kogyo Company Information
  99. 7.17.2 Nippon Zenyaku Kogyo Business Overview
  100. 7.17.3 Nippon Zenyaku Kogyo Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Nippon Zenyaku Kogyo Veterinary Drug Product Portfolio
  102. 7.17.5 Nippon Zenyaku Kogyo Recent Developments
  103. 7.18 Farmavet-Pasteur
  104. 7.18.1 Farmavet-Pasteur Company Information
  105. 7.18.2 Farmavet-Pasteur Business Overview
  106. 7.18.3 Farmavet-Pasteur Veterinary Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Farmavet-Pasteur Veterinary Drug Product Portfolio
  108. 7.18.5 Farmavet-Pasteur Recent Developments
8 North America
  1. 8.1 North America Veterinary Drug Market Size by Type
  2. 8.1.1 North America Veterinary Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Veterinary Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Veterinary Drug Price by Type (2021-2032)
  5. 8.2 North America Veterinary Drug Market Size by Application
  6. 8.2.1 North America Veterinary Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Veterinary Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Veterinary Drug Price by Application (2021-2032)
  9. 8.3 North America Veterinary Drug Market Size by Country
  10. 8.3.1 North America Veterinary Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Veterinary Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Veterinary Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Veterinary Drug Market Size by Type
  2. 9.1.1 Europe Veterinary Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Veterinary Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Veterinary Drug Price by Type (2021-2032)
  5. 9.2 Europe Veterinary Drug Market Size by Application
  6. 9.2.1 Europe Veterinary Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Veterinary Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Veterinary Drug Price by Application (2021-2032)
  9. 9.3 Europe Veterinary Drug Market Size by Country
  10. 9.3.1 Europe Veterinary Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Veterinary Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Veterinary Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Veterinary Drug Market Size by Type
  2. 10.1.1 China Veterinary Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Veterinary Drug Sales by Type (2021-2032)
  4. 10.1.3 China Veterinary Drug Price by Type (2021-2032)
  5. 10.2 China Veterinary Drug Market Size by Application
  6. 10.2.1 China Veterinary Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Veterinary Drug Sales by Application (2021-2032)
  8. 10.2.3 China Veterinary Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Veterinary Drug Market Size by Type
  2. 11.1.1 Asia Veterinary Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Veterinary Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Veterinary Drug Price by Type (2021-2032)
  5. 11.2 Asia Veterinary Drug Market Size by Application
  6. 11.2.1 Asia Veterinary Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Veterinary Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Veterinary Drug Price by Application (2021-2032)
  9. 11.3 Asia Veterinary Drug Market Size by Country
  10. 11.3.1 Asia Veterinary Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Veterinary Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Veterinary Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Veterinary Drug Market Size by Type
  2. 12.1.1 SAMEA Veterinary Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Veterinary Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Veterinary Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Veterinary Drug Market Size by Application
  6. 12.2.1 SAMEA Veterinary Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Veterinary Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Veterinary Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Veterinary Drug Market Size by Country
  10. 12.3.1 SAMEA Veterinary Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Veterinary Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Veterinary Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Veterinary Drug Value Chain Analysis
  2. 13.1.1 Veterinary Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Veterinary Drug Production Mode & Process
  6. 13.2 Veterinary Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Veterinary Drug Distributors
  9. 13.2.3 Veterinary Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst